Time series analysis of the new tiering pricing policy for generic medicines in South Korea. [PDF]
Park CM, Song I, Kim DS.
europepmc +1 more source
US Antibiotic Importation and Supply Chain Vulnerabilities.
Socal MP +5 more
europepmc +1 more source
Cost-Efficient and Fast At-Line Assessment of Content and Uniformity in Low-Dose Dimdazenil Capsules Using Transmission Raman Spectroscopy. [PDF]
Ma X +6 more
europepmc +1 more source
Pharmaceutical Co-Crystal Formulation of Rivaroxaban with Niacinamide: Preparation, Characterization, and In Vitro Release Evaluation. [PDF]
Solomon C +11 more
europepmc +1 more source
Methods of Thermal Analysis as Fast and Reliable Tools for Identification and Quantification of Active Ingredients in Commercially Available Drug Products. [PDF]
Wesolowski M.
europepmc +1 more source
Contemporary Techniques and Prospects in Pharmaceutical Tablet Surface Analysis. [PDF]
Finšgar M.
europepmc +1 more source
Study on the Adsorption Behavior of Preservatives in Multidose Eye Drops and Their Interaction with Packaging Materials. [PDF]
Guan H +6 more
europepmc +1 more source
Related searches:
Stable isotopic composition of the active pharmaceutical ingredient (API) naproxen
Journal of Pharmaceutical and Biomedical Analysis, 2005A survey of the multi-stable isotopic composition of an active pharmaceutical ingredient (API), naproxen, was performed to assess the potential of Isotope Ratio Mass Spectrometry (IRMS) to distinguish the provenance of APIs. Twenty-six lots of naproxen from six manufacturers representing four countries (Italy, India, Ireland, and the USA) were analyzed
A M, Wokovich +4 more
exaly +3 more sources
Establishing appropriate impurity specifications for active pharmaceutical ingredient (API) starting materials is an important component of the commercialization and registration of an API. Multiple sources and routes of manufacture of starting materials and the capability of the API synthetic process for tolerating impurities introduced with starting ...
Peter F, Gavin +3 more
exaly +3 more sources

